Sat, Oct 31, 2026中文About
Filings today 2 / Covered 1
Source: TDnet timely disclosures
Updated 10/31 09:30M&A / TOB 1 Guidance 0 Buybacks 0 Dividends 0 Capital 0 Earnings 0 People 0

Tsuruha Holdings H1 net profit up 48.5% to ¥30.3 billion, keeps forecast

Wed, Oct 07, 2026 15:30 JST Tsuruha Holdings Inc. (3391.T) Drugstores 中文

Tsuruha Holdings Inc. (3391) said on Oct. 7 that net profit attributable to owners of the parent rose 48.5% to ¥30.3 billion in the first half of the fiscal year ending February 2027, with net sales up 128.7% at ¥1.276 trillion, and kept its full-year forecast unchanged.

H1 net sales¥1.276 trillion (+128.7%)
H1 operating profit¥54.8 billion (+92.6%)
H1 net profit¥30.3 billion (+48.5%)
FY net profit forecast¥41.5 billion (-2.7%, unchanged)

Operating profit rose 92.6% to ¥54.8 billion, and ordinary profit increased 90.3% to ¥54.9 billion. EBITDA, defined as operating profit plus depreciation and goodwill amortization, grew 126.3% to ¥85.5 billion.

Earnings per share were ¥66.75, compared with ¥83.64 a year earlier, with both figures adjusted for a five-for-one stock split effective Sept. 1, 2025. The average number of shares during the period was 453,233,584, against 243,495,628 a year earlier.

ItemH1 resultYoYFY forecast
Net sales¥1.276 trillion+128.7%¥2.555 trillion
Operating profit¥54.8 billion+92.6%¥99.4 billion
Ordinary profit¥54.9 billion+90.3%¥98.1 billion
Net profit¥30.3 billion+48.5%¥41.5 billion

The company kept its forecast for the year ending Feb. 28, 2027, which calls for sales growth of 76.1%, a 57.7% rise in operating profit and a 2.7% decline in net profit, or ¥91.62 per share. It set an interim dividend of ¥24 per share and forecasts a year-end payout of ¥24, for an annual total of ¥48, unchanged from its previous forecast.

Tsuruha completed its business integration with Welcia Holdings on Dec. 1, 2025, after the year-earlier comparison period of March 1-Aug. 31, 2025. The current fiscal year is the first of a medium-term management plan running through the year ending February 2029. In the half, the group opened 53 stores and closed 77, ending August with 5,652 directly operated stores in Japan, 3,338 of which handle prescriptions, plus 36 stores overseas.

The company plans to file its semiannual securities report on Oct. 14, 2026, and to begin paying the interim dividend on Nov. 2, 2026.


Original filings
Related